Amikalla-M 500 Injection
Marketer
Skylla Pharmaceuticals
Salt Composition
Amikacin (500mg)
Overview Amikalla-M 500 Injection
Amikacin 500mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These include, but are not limited to, urinary tract, bone, joint, pulmonary (such as pneumonia), central nervous system, and bloodstream infections. Prophylactic use is also indicated in hospitalized individuals to deter infections. Amikacin 500mg Injection inhibits bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare professional, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Complete the entire course, regardless of symptom improvement; premature cessation may result in relapse or infection exacerbation. Frequently reported adverse effects include injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or treatment inefficacy warrant immediate medical consultation. High doses may rarely induce disequilibrium, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is paramount; routine monitoring of renal function, hearing, and urinalysis may be conducted. This antibiotic is contraindicated in pregnancy. Disclose pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Primary Ingredients of Amikalla-M 500 Injection
No text provided to rephrase.
Uses of Amikalla-M 500 Injection
Infections caused by bacteria
Major Benefits of Amikalla-M 500 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Amikalla-M 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Amikalla-M 500 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Amikalla-M 500 Injection works:
Amikacin 500mg Injection is a bacterial infection medication. Its mechanism of action involves inhibiting the production of crucial bacterial proteins, thus halting bacterial proliferation.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Amikalla-M 500 Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Amikacin 500mg injection poses a confirmed risk to the fetus and should not be administered during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Amikacin 500mg injection poses minimal risk to breastfeeding infants. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent threat to the nursing child.
DrivingUNSAFE
Amikalla-M 500 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Amikalla-M 500 Injection requires careful administration for individuals with impaired kidney function. Dosage modification for Amikalla-M 500 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Amikacin 500mg injection is likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Amikalla-M 500 Injection :
Should you forget a scheduled Amikalla-M 500 Injection, seek medical advice.
Facts to Know About Amikalla-M 500 Injection
| Label | Value |
|---|---|
| Chemical Classification | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently